|
Volumn 56, Issue 2, 2007, Pages 694-
|
Effect of the 34C>T variant in the AMPD1 gene on the clinical response to methotrexate in patients with rheumatoid arthritis: Comment on the article by Wessels et al [2]
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE;
ADENOSINE MONOPHOSPHATE DEAMINASE;
METHOTREXATE;
PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE;
AMPD1 GENE;
ANTIINFLAMMATORY ACTIVITY;
DISEASE ACTIVITY;
GENE;
GENETIC POLYMORPHISM;
HUMAN;
LETTER;
PHARMACOGENETICS;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
TREATMENT RESPONSE;
AMP DEAMINASE;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DRUG RESISTANCE;
HUMANS;
METHOTREXATE;
MUSCLE, SKELETAL;
PHARMACOGENETICS;
POLYMORPHISM, GENETIC;
TREATMENT OUTCOME;
VARIATION (GENETICS);
|
EID: 33847015997
PISSN: 00043591
EISSN: None
Source Type: Journal
DOI: 10.1002/art.22397 Document Type: Letter |
Times cited : (2)
|
References (4)
|